Clinical Trial Update: Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on the long-term safety, efficacy, and pharmacodynamics of Revestive (teduglutide) in pediatric patients with Short Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Revestive (teduglutide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Short Bowel Syndrome | Phase 4 | Status: COMPLETED